nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—CYP1A1—chronic obstructive pulmonary disease	0.691	1	CbGaD
Prazosin—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00144	0.00711	CcSEcCtD
Prazosin—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00143	0.00705	CcSEcCtD
Prazosin—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00138	0.00679	CcSEcCtD
Prazosin—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00678	CcSEcCtD
Prazosin—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00678	CcSEcCtD
Prazosin—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00136	0.00672	CcSEcCtD
Prazosin—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00668	CcSEcCtD
Prazosin—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00667	CcSEcCtD
Prazosin—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00131	0.00647	CcSEcCtD
Prazosin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.0013	0.00643	CcSEcCtD
Prazosin—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.0064	CcSEcCtD
Prazosin—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.0064	CcSEcCtD
Prazosin—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00625	CcSEcCtD
Prazosin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.0062	CcSEcCtD
Prazosin—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00619	CcSEcCtD
Prazosin—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.00125	0.00616	CcSEcCtD
Prazosin—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00608	CcSEcCtD
Prazosin—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00586	CcSEcCtD
Prazosin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.00575	CcSEcCtD
Prazosin—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00573	CcSEcCtD
Prazosin—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00566	CcSEcCtD
Prazosin—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.00563	CcSEcCtD
Prazosin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00113	0.0056	CcSEcCtD
Prazosin—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00553	CcSEcCtD
Prazosin—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00543	CcSEcCtD
Prazosin—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00539	CcSEcCtD
Prazosin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.00534	CcSEcCtD
Prazosin—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00531	CcSEcCtD
Prazosin—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00528	CcSEcCtD
Prazosin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00516	CcSEcCtD
Prazosin—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00512	CcSEcCtD
Prazosin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00512	CcSEcCtD
Prazosin—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.00508	CcSEcCtD
Prazosin—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.005	CcSEcCtD
Prazosin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.001	0.00496	CcSEcCtD
Prazosin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000996	0.00492	CcSEcCtD
Prazosin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000995	0.00491	CcSEcCtD
Prazosin—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000993	0.0049	CcSEcCtD
Prazosin—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000993	0.0049	CcSEcCtD
Prazosin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000989	0.00489	CcSEcCtD
Prazosin—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000989	0.00488	CcSEcCtD
Prazosin—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000977	0.00483	CcSEcCtD
Prazosin—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000969	0.00479	CcSEcCtD
Prazosin—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000964	0.00476	CcSEcCtD
Prazosin—Tension—Formoterol—chronic obstructive pulmonary disease	0.000964	0.00476	CcSEcCtD
Prazosin—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000954	0.00471	CcSEcCtD
Prazosin—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000954	0.00471	CcSEcCtD
Prazosin—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000953	0.0047	CcSEcCtD
Prazosin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000938	0.00463	CcSEcCtD
Prazosin—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000929	0.00459	CcSEcCtD
Prazosin—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000911	0.0045	CcSEcCtD
Prazosin—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000911	0.0045	CcSEcCtD
Prazosin—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00091	0.00449	CcSEcCtD
Prazosin—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000906	0.00447	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000905	0.00447	CcSEcCtD
Prazosin—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000901	0.00445	CcSEcCtD
Prazosin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000898	0.00444	CcSEcCtD
Prazosin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000892	0.0044	CcSEcCtD
Prazosin—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000886	0.00437	CcSEcCtD
Prazosin—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000886	0.00437	CcSEcCtD
Prazosin—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000868	0.00429	CcSEcCtD
Prazosin—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000868	0.00429	CcSEcCtD
Prazosin—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00086	0.00425	CcSEcCtD
Prazosin—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00085	0.0042	CcSEcCtD
Prazosin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000849	0.00419	CcSEcCtD
Prazosin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000837	0.00413	CcSEcCtD
Prazosin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000836	0.00413	CcSEcCtD
Prazosin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000836	0.00413	CcSEcCtD
Prazosin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000836	0.00413	CcSEcCtD
Prazosin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000833	0.00411	CcSEcCtD
Prazosin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000833	0.00411	CcSEcCtD
Prazosin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000832	0.00411	CcSEcCtD
Prazosin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000826	0.00408	CcSEcCtD
Prazosin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000826	0.00408	CcSEcCtD
Prazosin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00082	0.00405	CcSEcCtD
Prazosin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000819	0.00404	CcSEcCtD
Prazosin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000818	0.00404	CcSEcCtD
Prazosin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000818	0.00404	CcSEcCtD
Prazosin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000815	0.00402	CcSEcCtD
Prazosin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000802	0.00396	CcSEcCtD
Prazosin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000802	0.00396	CcSEcCtD
Prazosin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00079	0.0039	CcSEcCtD
Prazosin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000789	0.0039	CcSEcCtD
Prazosin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000785	0.00388	CcSEcCtD
Prazosin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000782	0.00386	CcSEcCtD
Prazosin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000782	0.00386	CcSEcCtD
Prazosin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00078	0.00385	CcSEcCtD
Prazosin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000776	0.00383	CcSEcCtD
Prazosin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000772	0.00381	CcSEcCtD
Prazosin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000757	0.00374	CcSEcCtD
Prazosin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000748	0.0037	CcSEcCtD
Prazosin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000745	0.00368	CcSEcCtD
Prazosin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.00368	CcSEcCtD
Prazosin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000744	0.00367	CcSEcCtD
Prazosin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000739	0.00365	CcSEcCtD
Prazosin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000732	0.00361	CcSEcCtD
Prazosin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000732	0.00361	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00073	0.00361	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00073	0.00361	CcSEcCtD
Prazosin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000725	0.00358	CcSEcCtD
Prazosin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000725	0.00358	CcSEcCtD
Prazosin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000721	0.00356	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000715	0.00353	CcSEcCtD
Prazosin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000715	0.00353	CcSEcCtD
Prazosin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000715	0.00353	CcSEcCtD
Prazosin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000713	0.00352	CcSEcCtD
Prazosin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000713	0.00352	CcSEcCtD
Prazosin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00071	0.00351	CcSEcCtD
Prazosin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000705	0.00348	CcSEcCtD
Prazosin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000703	0.00347	CcSEcCtD
Prazosin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000698	0.00345	CcSEcCtD
Prazosin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000696	0.00344	CcSEcCtD
Prazosin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000691	0.00341	CcSEcCtD
Prazosin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000691	0.00341	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00069	0.00341	CcSEcCtD
Prazosin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000685	0.00338	CcSEcCtD
Prazosin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000685	0.00338	CcSEcCtD
Prazosin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000685	0.00338	CcSEcCtD
Prazosin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000685	0.00338	CcSEcCtD
Prazosin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00338	CcSEcCtD
Prazosin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00068	0.00336	CcSEcCtD
Prazosin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000677	0.00334	CcSEcCtD
Prazosin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00333	CcSEcCtD
Prazosin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000673	0.00332	CcSEcCtD
Prazosin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000671	0.00332	CcSEcCtD
Prazosin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00067	0.00331	CcSEcCtD
Prazosin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000664	0.00328	CcSEcCtD
Prazosin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000663	0.00328	CcSEcCtD
Prazosin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000661	0.00326	CcSEcCtD
Prazosin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000661	0.00326	CcSEcCtD
Prazosin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00066	0.00326	CcSEcCtD
Prazosin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000657	0.00324	CcSEcCtD
Prazosin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000653	0.00322	CcSEcCtD
Prazosin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000647	0.0032	CcSEcCtD
Prazosin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000647	0.0032	CcSEcCtD
Prazosin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000637	0.00314	CcSEcCtD
Prazosin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000637	0.00314	CcSEcCtD
Prazosin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000634	0.00313	CcSEcCtD
Prazosin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000634	0.00313	CcSEcCtD
Prazosin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000632	0.00312	CcSEcCtD
Prazosin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000626	0.00309	CcSEcCtD
Prazosin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000626	0.00309	CcSEcCtD
Prazosin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000626	0.00309	CcSEcCtD
Prazosin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000624	0.00308	CcSEcCtD
Prazosin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000624	0.00308	CcSEcCtD
Prazosin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000622	0.00307	CcSEcCtD
Prazosin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000622	0.00307	CcSEcCtD
Prazosin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000621	0.00306	CcSEcCtD
Prazosin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000601	0.00297	CcSEcCtD
Prazosin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000598	0.00295	CcSEcCtD
Prazosin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000591	0.00292	CcSEcCtD
Prazosin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000591	0.00292	CcSEcCtD
Prazosin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00059	0.00291	CcSEcCtD
Prazosin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000578	0.00286	CcSEcCtD
Prazosin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000575	0.00284	CcSEcCtD
Prazosin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000575	0.00284	CcSEcCtD
Prazosin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000567	0.0028	CcSEcCtD
Prazosin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000567	0.0028	CcSEcCtD
Prazosin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000563	0.00278	CcSEcCtD
Prazosin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000558	0.00275	CcSEcCtD
Prazosin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000555	0.00274	CcSEcCtD
Prazosin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000548	0.00271	CcSEcCtD
Prazosin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000548	0.00271	CcSEcCtD
Prazosin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000544	0.00269	CcSEcCtD
Prazosin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000543	0.00268	CcSEcCtD
Prazosin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00054	0.00267	CcSEcCtD
Prazosin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000537	0.00265	CcSEcCtD
Prazosin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.00264	CcSEcCtD
Prazosin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00053	0.00262	CcSEcCtD
Prazosin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00053	0.00262	CcSEcCtD
Prazosin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000519	0.00256	CcSEcCtD
Prazosin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000518	0.00256	CcSEcCtD
Prazosin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000511	0.00252	CcSEcCtD
Prazosin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00252	CcSEcCtD
Prazosin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00252	CcSEcCtD
Prazosin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000505	0.0025	CcSEcCtD
Prazosin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.0025	CcSEcCtD
Prazosin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00249	CcSEcCtD
Prazosin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00249	CcSEcCtD
Prazosin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000502	0.00248	CcSEcCtD
Prazosin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000502	0.00248	CcSEcCtD
Prazosin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000501	0.00248	CcSEcCtD
Prazosin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.00247	CcSEcCtD
Prazosin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000499	0.00247	CcSEcCtD
Prazosin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000495	0.00244	CcSEcCtD
Prazosin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000495	0.00244	CcSEcCtD
Prazosin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000494	0.00244	CcSEcCtD
Prazosin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000492	0.00243	CcSEcCtD
Prazosin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00238	CcSEcCtD
Prazosin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00048	0.00237	CcSEcCtD
Prazosin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000478	0.00236	CcSEcCtD
Prazosin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00236	CcSEcCtD
Prazosin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000477	0.00236	CcSEcCtD
Prazosin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00235	CcSEcCtD
Prazosin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00235	CcSEcCtD
Prazosin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00235	CcSEcCtD
Prazosin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00234	CcSEcCtD
Prazosin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000468	0.00231	CcSEcCtD
Prazosin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000466	0.0023	CcSEcCtD
Prazosin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000452	0.00223	CcSEcCtD
Prazosin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00222	CcSEcCtD
Prazosin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000447	0.00221	CcSEcCtD
Prazosin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000442	0.00218	CcSEcCtD
Prazosin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000434	0.00214	CcSEcCtD
Prazosin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.00211	CcSEcCtD
Prazosin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000424	0.00209	CcSEcCtD
Prazosin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00042	0.00207	CcSEcCtD
Prazosin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000412	0.00203	CcSEcCtD
Prazosin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000393	0.00194	CcSEcCtD
Prazosin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000392	0.00194	CcSEcCtD
Prazosin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00039	0.00192	CcSEcCtD
Prazosin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000371	0.00183	CcSEcCtD
Prazosin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000364	0.0018	CcSEcCtD
Prazosin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000359	0.00177	CcSEcCtD
Prazosin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000358	0.00177	CcSEcCtD
Prazosin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00172	CcSEcCtD
Prazosin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000347	0.00171	CcSEcCtD
Prazosin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000347	0.00171	CcSEcCtD
Prazosin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000345	0.0017	CcSEcCtD
Prazosin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00034	0.00168	CcSEcCtD
Prazosin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000329	0.00162	CcSEcCtD
Prazosin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000325	0.00161	CcSEcCtD
Prazosin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00158	CcSEcCtD
Prazosin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000315	0.00156	CcSEcCtD
Prazosin—Shock—Prednisone—chronic obstructive pulmonary disease	0.00031	0.00153	CcSEcCtD
Prazosin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000308	0.00152	CcSEcCtD
Prazosin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000305	0.00151	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00142	CcSEcCtD
Prazosin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000287	0.00142	CcSEcCtD
Prazosin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000285	0.00141	CcSEcCtD
Prazosin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000283	0.0014	CcSEcCtD
Prazosin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.00135	CcSEcCtD
Prazosin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000273	0.00135	CcSEcCtD
Prazosin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000272	0.00134	CcSEcCtD
Prazosin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.00134	CcSEcCtD
Prazosin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00027	0.00133	CcSEcCtD
Prazosin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00026	0.00128	CcSEcCtD
Prazosin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00127	CcSEcCtD
Prazosin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00124	CcSEcCtD
Prazosin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00123	CcSEcCtD
Prazosin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00115	CcSEcCtD
Prazosin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00112	CcSEcCtD
Prazosin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000223	0.0011	CcSEcCtD
Prazosin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00107	CcSEcCtD
Prazosin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00103	CcSEcCtD
Prazosin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00099	CcSEcCtD
Prazosin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000982	CcSEcCtD
Prazosin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000981	CcSEcCtD
Prazosin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000976	CcSEcCtD
Prazosin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000925	CcSEcCtD
Prazosin—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.55e-05	0.000333	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.53e-05	0.000332	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.53e-05	0.000331	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.52e-05	0.00033	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.5e-05	0.000328	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.46e-05	0.000325	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.45e-05	0.000324	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.42e-05	0.000321	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.42e-05	0.000321	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.42e-05	0.000321	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.42e-05	0.00032	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.41e-05	0.000319	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.4e-05	0.000319	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.4e-05	0.000319	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.39e-05	0.000318	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.35e-05	0.000314	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.3e-05	0.000309	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.29e-05	0.000308	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.28e-05	0.000308	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.27e-05	0.000307	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.25e-05	0.000305	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.24e-05	0.000304	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.22e-05	0.000302	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.17e-05	0.000298	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.12e-05	0.000293	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.12e-05	0.000293	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.12e-05	0.000293	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.09e-05	0.00029	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.09e-05	0.000289	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.09e-05	0.000289	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.04e-05	0.000285	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.03e-05	0.000285	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.03e-05	0.000285	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.02e-05	0.000283	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.02e-05	0.000283	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.01e-05	0.000282	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3e-05	0.000281	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.98e-05	0.000279	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.98e-05	0.000279	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	2.97e-05	0.000279	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.96e-05	0.000278	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.95e-05	0.000276	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.93e-05	0.000275	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	2.9e-05	0.000272	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.88e-05	0.00027	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.88e-05	0.00027	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.84e-05	0.000267	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.84e-05	0.000266	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.83e-05	0.000266	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.82e-05	0.000265	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.82e-05	0.000264	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.8e-05	0.000263	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.78e-05	0.000261	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.78e-05	0.00026	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.72e-05	0.000255	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.72e-05	0.000255	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.7e-05	0.000253	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.7e-05	0.000253	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.68e-05	0.000251	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	2.65e-05	0.000248	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.65e-05	0.000248	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.62e-05	0.000246	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.6e-05	0.000244	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.58e-05	0.000242	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.58e-05	0.000242	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.57e-05	0.000241	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.57e-05	0.000241	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.54e-05	0.000238	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.54e-05	0.000238	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.53e-05	0.000237	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.52e-05	0.000236	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.51e-05	0.000236	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.5e-05	0.000234	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.48e-05	0.000232	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.47e-05	0.000231	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.45e-05	0.00023	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.44e-05	0.000229	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.44e-05	0.000229	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—ALB—chronic obstructive pulmonary disease	2.43e-05	0.000228	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.4e-05	0.000225	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.39e-05	0.000224	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.37e-05	0.000222	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.37e-05	0.000222	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.36e-05	0.000221	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.34e-05	0.00022	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.34e-05	0.00022	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.33e-05	0.000219	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.33e-05	0.000219	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.33e-05	0.000218	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—NOS3—chronic obstructive pulmonary disease	2.33e-05	0.000218	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.32e-05	0.000218	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.31e-05	0.000216	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.29e-05	0.000215	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.27e-05	0.000213	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.25e-05	0.000211	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.24e-05	0.00021	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.22e-05	0.000208	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.21e-05	0.000207	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.19e-05	0.000206	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.14e-05	0.000201	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.11e-05	0.000198	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.11e-05	0.000198	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.1e-05	0.000197	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.1e-05	0.000197	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.09e-05	0.000196	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.08e-05	0.000195	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.06e-05	0.000194	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.06e-05	0.000193	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.05e-05	0.000192	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	2.04e-05	0.000191	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.03e-05	0.000191	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.03e-05	0.00019	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.03e-05	0.00019	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.02e-05	0.000189	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.01e-05	0.000189	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.01e-05	0.000188	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.01e-05	0.000188	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.93e-05	0.000181	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.92e-05	0.00018	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.92e-05	0.00018	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.91e-05	0.000179	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.9e-05	0.000179	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.89e-05	0.000178	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.88e-05	0.000176	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.88e-05	0.000176	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.87e-05	0.000175	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.84e-05	0.000173	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.83e-05	0.000172	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.83e-05	0.000171	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.82e-05	0.000171	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.8e-05	0.000169	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.78e-05	0.000167	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.77e-05	0.000166	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.77e-05	0.000166	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.76e-05	0.000165	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.76e-05	0.000165	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.75e-05	0.000164	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.74e-05	0.000163	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.74e-05	0.000163	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.72e-05	0.000161	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.000161	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.7e-05	0.00016	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.69e-05	0.000159	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.69e-05	0.000158	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.68e-05	0.000157	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.64e-05	0.000154	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.64e-05	0.000153	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.62e-05	0.000152	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.59e-05	0.000149	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.000148	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.56e-05	0.000146	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.000146	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	1.55e-05	0.000145	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.55e-05	0.000145	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.54e-05	0.000145	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	1.54e-05	0.000144	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.52e-05	0.000143	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.49e-05	0.00014	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.47e-05	0.000138	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.47e-05	0.000138	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.46e-05	0.000137	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.46e-05	0.000137	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.45e-05	0.000136	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.44e-05	0.000135	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.42e-05	0.000133	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.41e-05	0.000132	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.41e-05	0.000132	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.39e-05	0.000131	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.39e-05	0.00013	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.39e-05	0.00013	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.38e-05	0.00013	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.38e-05	0.00013	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.36e-05	0.000127	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.35e-05	0.000126	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.33e-05	0.000125	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.32e-05	0.000124	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.000121	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.29e-05	0.000121	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.28e-05	0.00012	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.28e-05	0.00012	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.27e-05	0.000119	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.25e-05	0.000117	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.23e-05	0.000115	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	0.000115	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.22e-05	0.000115	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	1.2e-05	0.000113	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.19e-05	0.000111	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.18e-05	0.000111	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.17e-05	0.000109	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	1.15e-05	0.000108	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.14e-05	0.000107	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.13e-05	0.000106	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.13e-05	0.000106	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.09e-05	0.000102	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.09e-05	0.000102	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.09e-05	0.000102	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.07e-05	0.0001	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.07e-05	9.99e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.06e-05	9.92e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.04e-05	9.78e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.04e-05	9.72e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.04e-05	9.71e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.03e-05	9.7e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.02e-05	9.55e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.01e-05	9.5e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.01e-05	9.46e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.97e-06	9.36e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.85e-06	9.23e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.83e-06	9.22e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.63e-06	9.04e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.37e-06	8.78e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.3e-06	8.72e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.2e-06	8.63e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.15e-06	8.58e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.12e-06	8.55e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.95e-06	8.39e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.83e-06	8.28e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.75e-06	8.2e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.55e-06	8.01e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.41e-06	7.89e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.4e-06	7.87e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	8.33e-06	7.81e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.32e-06	7.8e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.23e-06	7.72e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.19e-06	7.68e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.13e-06	7.62e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.1e-06	7.6e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.97e-06	7.47e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.95e-06	7.45e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.73e-06	7.25e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.72e-06	7.24e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.66e-06	7.18e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.57e-06	7.1e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.47e-06	7.01e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.01e-06	6.57e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.94e-06	6.51e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.91e-06	6.48e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.86e-06	6.43e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.72e-06	6.3e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.67e-06	6.26e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.37e-06	5.97e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.35e-06	5.96e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.33e-06	5.93e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.25e-06	5.86e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.11e-06	5.73e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.82e-06	5.46e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.64e-06	5.29e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.24e-06	4.92e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.17e-06	4.85e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.8e-06	4.5e-05	CbGpPWpGaD
